Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-27

Clinical Trial Update: Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing a new paracetamol formulation to ibuprofen for headache was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)
  • Paracetamol (acetaminophen) formulation (paracetamol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pain | Phase 3 | Status: TERMINATED | Results posted: 2017-07-27